Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells.
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);半胱氨酸天冬氨酸蛋白酶3(Caspase 3);半胱氨酸天冬氨酸蛋白酶7(Caspase 7);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);顺铂(Cisplatin);DNA碎片裂(DNA Fragmentation);DNA甲基化(DNA Methylation);剂量效应关系, 药物(Dose-Response Relationship, Drug);抗药性, 肿瘤(Drug Resistance, Neoplasm);药物协同作用(Drug Synergism);后成说, 遗传(Epigenesis, Genetic);女(雌)性(Female);荧光抗体技术(Fluorescent Antibody Technique);棉酚(Gossypol);组蛋白脱乙酰基酶类(Histone Deacetylases);人类(Humans);卵巢肿瘤(Ovarian Neoplasms)
DOI
10.1007/s11033-012-2469-z
PMID
23269627
发布时间
2021-10-21
- 浏览54

Molecular biology reports
3925-33页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文